类风湿关节炎抗体库的高密度肽阵列全面分析
本研究用覆盖人类全蛋白质组(含瓜氨酸化和高瓜氨酸化肽段)的高密度肽阵列分析18例RA患者和8例对照的血清抗体谱,构建8表位诊断标志物,并在92例和181例两个队列中验证;验证队列特异度94.4%、敏感度85%,性能优于Abnova CCP2检测。
要点
- 8表位诊断标志物在验证队列特异度94.4%、敏感度85%。
- 该标志物性能与Abnova CCP2检测相当或更优。
核心结论
- 高密度肽阵列抗体谱分析可识别新的RA特异性表位,并构建出与Abnova CCP2检测特异度相当、敏感度更高的新型诊断标志物。
研究设计与样本
- 基于RA特异性表位构建8表位诊断标志物,在92例血清(29例对照、63例RA)中建立,并在181例血清(54例对照、127例RA)独立队列中验证。
主要发现
- 初始队列中8表位标志物特异度96.6%、敏感度92.1%。
- 验证队列中8表位标志物特异度94.4%、敏感度85%。
- 两个队列中8表位标志物性能均优于Abnova CCP2检测。
- 肽阵列数据识别出新的RA特异性表位。
关键数值与推荐
- 抗瓜氨酸化蛋白自身抗体在RA患者中占64-89%,特异度88-99%。
临床怎么用
- 8表位诊断标志物可作为RA诊断的候选血清学检测,性能与Abnova CCP2检测相当或更优。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Autoantibodies against citrullinated proteins are found in 64-89% of rheumatoid arthritis (RA) patients, with 88-99% specificity. This study was undertaken to create an unbiased, comprehensive profile of serum antibodies against the human proteome, including the citrullinome and the homocitrullinome, in RA patients, using a high-density peptide array. METHODS: Our high-density peptide array, consisting of >4.6 million peptides, contained the entire annotated human proteome. The 20,246 proteins were represented as overlapping 16-mer peptides. In addition to native peptides, citrullinated and homocitrullinated peptides were included, as substitutions for arginine and lysine, and provided a comprehensive screen against all possible epitopes. Twenty-six serum samples (from 8 controls and 18 RA patients) were profiled on the high-density peptide array. Using RA-specific epitopes, we constructed an 8-epitope diagnostic biomarker on a Gyrolab xPlore instrument with a cohort of 92 serum samples (from 29 controls and 63 RA patients). The diagnostic biomarker was further validated with an independent cohort of 181 serum samples (from 54 controls and 127 RA patients). RESULTS: In the initial cohort the diagnostic performance of the 8-epitope biomarker yielded 96.6% specificity and 92.1% sensitivity. The overall diagnostic performance in the validation cohort was 94.4% specificity and 85% sensitivity. In both cohorts, the performance of the 8-epitope diagnostic biomarker compared favorably against the Abnova cyclic citrullinated peptide 2 (CCP2) assay. Using data from the peptide array, we identified novel RA-specific epitopes and formed the basis of a new RA diagnostic assay. CONCLUSION: Comprehensive antibody profiling using a high-density peptide array not only identified novel RA-specific epitopes but also allowed us to construct a novel diagnostic biomarker that is as specific as and more sensitive than the Abnova CCP2 assay.
引用
- Lo KC, Sullivan E, Bannen RM, et al. Comprehensive Profiling of the Rheumatoid Arthritis Antibody Repertoire. Arthritis Rheumatol. 2019. PMID: 31449733. doi:10.1002/art.41089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。